Carlsmed, Inc. Interest Expense
Carlsmed, Inc. (CARL) reported Interest Expense of $313.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-05
- Carlsmed, Inc. interest expense for the quarter ending 2026-06-30 was $313.00K, a 13.77% decline year-over-year.
- Carlsmed, Inc. interest expense for the quarter ending 2026-03-31 was $311.00K, a 12.89% decline year-over-year.
- Carlsmed, Inc. interest expense for the quarter ending 2025-12-31 was $330.00K, a 12.70% decline year-over-year.
- Carlsmed, Inc. interest expense for the quarter ending 2025-09-30 was $380.00K, a 5.47% decline year-over-year.
- Carlsmed, Inc. interest expense for fiscal 2025 was $1.43M, a 8.25% increase from fiscal 2024.
- Carlsmed, Inc. interest expense for fiscal 2024 was $1.32M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $313.00K 10-Q · filed 2026-08-05 | $624.00K 10-Q · filed 2026-08-05 | $954.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $311.00K 10-Q · filed 2026-05-05 | $641.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.02M derived: sum of 3 quarters · filed 2026-05-05 | $1.38M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $710.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.07M derived: sum of 3 quarters · filed 2026-08-05 | $1.43M 10-K · filed 2026-02-25 |
| 2025-09-30 | $380.00K 10-Q · filed 2025-11-06 | $743.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.10M 10-Q · filed 2025-11-06 | $1.48M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $363.00K 10-Q · filed 2026-08-05 | $720.00K 10-Q · filed 2026-08-05 | $1.10M derived: sum of 3 quarters · filed 2026-08-05 | $1.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $357.00K 10-Q · filed 2026-05-05 | $735.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.14M derived: sum of 3 quarters · filed 2026-05-05 | $1.46M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $378.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $780.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.10M derived: sum of 3 quarters · filed 2026-02-25 | $1.32M 10-K · filed 2026-02-25 |
| 2024-09-30 | $402.00K 10-Q · filed 2025-11-06 | $727.00K derived: sum of 2 quarters · filed 2025-11-06 | $943.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $325.00K 10-Q · filed 2025-08-28 | $541.00K 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |